Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel

References

• Raghunath S, O’Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005;22:55–63.
   PubMed Web of Science ®Google Scholar
• Lassen A, Hallas J, Schaffalitzky De Muckadell OB. Use of anti-secretory medication: a population-based cohort study. Aliment Pharmacol Ther 2004;20:577–83.
   PubMed Web of Science ®Google Scholar
• McColl KEL, Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 2009;137:20–2.
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1392–413; 1413.e1–5.
   PubMed Web of Science ®Google Scholar
• Manabe N, Haruma K, Ito M, Takahashi N, Takasugi H, Wada Y, et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial. Dis Esophagus 2012;25:373–80.
   PubMed Web of Science ®Google Scholar
• Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther 2003;17:1171–8.
   PubMedGoogle Scholar
• Chey WD, Mody RR, Wu EQ, Chen L, Kothari S, Persson B, et al. Treatment patterns and symptom control in patients with GERD: US community-based survey. Curr Med Res Opin 2009;25:1869–78.
   PubMed Web of Science ®Google Scholar
• Furu K, Straume B. Use of antacids in a general population: the impact of health-related variables, lifestyle and sociodemographic characteristics. J Clin Epidemiol 1999;52:509–16.
   PubMed Web of Science ®Google Scholar
• Raghunath AS, Hungin a PS, Mason J, Jackson W. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors. Aliment Pharmacol Ther 2009;29:431–9.
   PubMed Web of Science ®Google Scholar
• Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MC, Kuipers EJ. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006;24:377–85.
   PubMed Web of Science ®Google Scholar
• Hungin APS, Hill C, Molloy-Bland M, Raghunath A. Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10:109–16.
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ, Boeckxstaens G. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients? Gut 2012;61:1501–9.
   PubMed Web of Science ®Google Scholar
• Reimer C, Bytzer P. Management of laryngopharyngeal reflux with proton pump inhibitors. Ther Clin Risk Manag 2008;4:225–33.
   PubMedGoogle Scholar
• van Pinxteren B, Sigterman KE, Bonis P, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2010:CD002095.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. NICE Clinical Guideline 17: Managing dyspepsia in adults in primary care. Available from http://guidance.nice.org.uk/CG17. Access date 20.02.2014 2004.
   Google Scholar
• Masaany M, Marina MB, Sharifa Ezat WP, Sani A. Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. J Laryngol Otol 2011;125:502–8.
   PubMedGoogle Scholar
• Abrahamsen B, Eiken P, Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 2011;171:998–1004.
   PubMed Web of Science ®Google Scholar
• Howell M, Novack V. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784–90.
   PubMed Web of Science ®Google Scholar
• Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol 2013;27:443–54.
   PubMed Web of Science ®Google Scholar
• Medstat.dk. Total sale of PPI and H2RA in Denmark 1996–2012. Danish National Institute for Health Data and Disease Control. Available from www.medstat.dk/en. Access date 20.02.2014.
   Google Scholar
• Anon. Total sales of medicines in Denmark, 2008–2012. Report from The Danish Medicines Agency. 2013. Available from www.ssi.dk. Access date 29.04.2014; 2013:2008–2012.
   Google Scholar
• Cahir C, Fahey T, Tilson L, Teljeur C, Bennett K. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines. BMC Health Serv Res 2012;12:408.
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275–85.
   PubMed Web of Science ®Google Scholar
• Reimer C, Bytzer P. A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease. Scand J Gastroenterol 2009;44:394–400.
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Use of Information Technology in the Danish Population 2012. Available from http://www.dst.dk/en. Access date 20.02.2014 2013.
   Google Scholar
• Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population–the Kalixanda study. Aliment Pharmacol Ther 2006;23:1725–33.
   PubMed Web of Science ®Google Scholar